Sweroside

Sweroside

SCHEMBL307117

C=C[C@H]1[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)OC=C2C(=O)OCC[C@H]21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 9/20 1.00
MAPT P10636 2/20 0.42
PTPN1 P18031 6/20 0.42
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sweroside SCHEMBL14278967 1.00 STAT3 (1.00) STAT3MAPTPTPN1MEN1KMT2A
SCHEMBL14305641 0.85 STAT3 (0.73) STAT3MAPTPTPN1MEN1KMT2A
SCHEMBL14534198 0.85 STAT3 (0.73) STAT3MAPTPTPN1MEN1KMT2A
SCHEMBL28267368 0.84 STAT3 (0.72) STAT3MAPTPTPN1MEN1KMT2A
SCHEMBL21807732 0.84 STAT3 (0.72) STAT3MAPTPTPN1MEN1KMT2A
SCHEMBL29425739 0.83 STAT3 (0.69) STAT3PTPN1MEN1KMT2A
SCHEMBL29655347 0.81 STAT3 (0.67) STAT3PTPN1
SCHEMBL29471040 0.81 STAT3 (0.68) STAT3MAPT
SCHEMBL29471039 0.81 STAT3 (0.68) STAT3MAPT
SCHEMBL29426226 0.80 STAT3 (0.64) STAT3MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 903 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250352602-A1 DIETARY SUPPLEMENTS AND METHODS FOR REDUCING INFLAMMATION MELALEUCA INC (US) 2025-11-20 US claimed
EP-4650770-A1 METHOD FOR CONSTRUCTING CHICORY-PORIA COMPOUND FINGERPRINT, AND FINGERPRINT AND USE THEREOF Beijing University of Chinese Medicine (CN) 2025-11-19 EP claimed
EP-4615506-A1 USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES Sahin, Fikret (TR) 2025-09-17 EP claimed
US-20250281637-A1 AU, AG AND RICH PHYTOCHEMICAL PAYLOAD NANOMATERIALS, ANTIVIRAL/ANTIBACTERIAL PRODUCTS AND SYNTHESIS METHODS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2025-09-11 US claimed
EP-4379068-B1 IRIDOID OR SECO-IRIDOID DERIVATIVES AND THEIR USE IN A TANNING PROCESS INSTITUT NAT DES SCIENCES APPLIQUEES DE ROUEN (FR) 2025-06-04 EP claimed
CN-119367254-B Morroniside-enriched cornel fruit extract and preparation method and application thereof 懿奈(上海)生物科技有限公司 2025-04-11 CN claimed
US-12257232-B2 Methods and pharmaceutical compositions for the treatment of FGFR3-related chondrodysplasias INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 2025-03-25 US claimed
CN-119367254-A Morroniside-enriched cornel fruit extract and preparation method and application thereof 懿奈(上海)生物科技有限公司 2025-01-28 CN claimed
WO-2024258363-A1 USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES SAHIN FIKRET (TR) 2024-12-19 WO claimed
CN-119119068-A Monoterpene indole-like alkaloid, preparation method and application thereof, AChE inhibitor and medicine for preventing and treating neurodegenerative diseases 大理大学 2024-12-13 CN claimed
CN-1824161-A Compound joint convalscence medicine HE SHICHAO (CN) 2006-08-30 CN claimed
CN-1730027-A Method for preparing anti-hepatitis active part from swertia main pharmaceutical plant QINGHAI PULANTE PHARMACEUTICAL (CN) 2006-02-08 CN claimed
US-20060014240-A1 Extraction and purification method of active constituents from stem of lonicera japonica thunb., its usage for anti-inflammatory and analgesic drug SK CHEMICALS CO. LTD. (KR) 2006-01-19 US claimed
CN-1686141-A Medicinal composition for treating hepatitis and diabetes KUNMING SHENGWUGU MEDICINE INS (CN) 2005-10-26 CN claimed
CN-1684699-A Method for extracting and purifying active ingredients from honeysuckle stem, and application of active ingredients in anti-inflammatory and analgesic drugs SK CHEMICALS CO LTD (KR) 2005-10-19 CN claimed
CN-1634520-A Preparation process of Tibet capilary artemisia BEIJING PULANTE PHARMACEUTICAL (CN) 2005-07-06 CN claimed
EP-1536811-A1 EXTRACTION AND PURIFICATION METHOD OF ACTIVE CONSTITUENTS FROM STEM OF i LONICERA JAPONICA /i THUNB., ITS USAGE FOR ANTI-INFLAMMATORY AND ANALGESIC DRUG SK Chemicals, Co., Ltd. (KR) 2005-06-08 EP claimed
CN-1510037-A Cornus officinalis extract, extraction method thereof and application of extract in preparation of medicines and health-care products 首都医科大学宣武医院 2004-07-07 CN claimed
WO-2004024172-A1 EXTRACTION AND PURIFICATION METHOD OF ACTIVE CONSTITUENTS FROM STEM OF LONICERA JAPONICA THUNB., ITS USAGE FOR ANTI-INFLAMMATORY AND ANALGESIC DRUG SK CHEMICALS, CO., LTD. (KR) 2004-03-25 WO claimed
CN-1424319-A Dogwood extract and its preparing method and use XUANWU HOSPITAL CAPITAL MEDICA (CN) 2003-06-18 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250281637-A1 AU, AG AND RICH PHYTOCHEMICAL PAYLOAD NANOMATERIALS, ANTIVIRAL/ANTIBACTERIAL PRODUCTS AND SYNTHESIS METHODS FUT6, SP1, UGGT1 STAT3 1285/4885MAPT 551/4885PTPN1 4720/4885
US-20060014240-A1 Extraction and purification method of active constituents from stem of lonicera japonica thunb., its usage for anti-inflammatory and analgesic drug SENP7, LONP1, SYMPK STAT3 785/4885MAPT 3260/4885PTPN1 4475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.